Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$465,693
+$250,689 QoQ
Shares Held
3,104
+47.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#372
of 594 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $6,325,147 across 7 Diagnostics & Research names. GH ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,021 | $2,581,847 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,316 | $2,163,869 | |
| 3 | GH |
Guardant Health, Inc.
This page
|
3,104 | $465,693 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,987 | $383,928 | |
| 5 | NTRA |
Natera, Inc.
|
1,338 | $363,200 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,290 | $235,595 | |
| 7 | MYGN |
Myriad Genetics Inc
|
22,945 | $131,015 |
All Filings in GH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465,693 | 3,104 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $215,004 | 2,105 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $1,205,494 | 28,298 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $792,986 | 25,957 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $438,222 | 19,103 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $445,329 | 15,420 | Shares | Sole | 2024-08-09 | |
| 2021-12-31 | $737,947 | 7,378 | Shares | Sole | 2022-02-11 | |
| 2020-03-31 | $205,320 | 2,950 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||